Hepatite A: avaliação do custo-beneficio da prevenção pela vacina - Paraná, Brasil

Zahdi, Mariana Ribas; Maluf Junior, Ivan; Maluf, Eliane Mara Cesario Pereira.
Rev. bras. med. fam. comunidade ; 4(16): 281-288, nov. 2009. ilus., tab.
Artigo em Português | LILACS | ID: biblio-881067

Documentos relacionados

  1. Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review.
  2. Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine.
  3. Relationship between cases of hepatitis A and flood areas, municipality of Encantado, Rio Grande do Sul, Brazil.
  4. Investigating acute hepatitis of unknown origin in children.
  5. A Randomized Clinical Trial of 1-Dose vs Accelerated 2-Dose Schedule for Hepatitis A Virus (HAV) Revaccination Among People With Human Immunodeficiency Virus Who Were Nonresponders or Had Seroreversion After Primary HAV Vaccination.
  6. Hepatitis A: the costs and benefits of the disease prevention by vaccine, Paraná, Brazil.
  7. A retrospective study assessing the clinical outcomes and costs of acute hepatitis A in Cape Town, South Africa.
  8. Cost-effectiveness of Hepatitis A vaccination in a developed and developing country.
  9. Homelessness and Hepatitis A-San Diego County, 2016-2018.
  10. Hepatitis A Exposure Response and Outbreak Prevention in a Large Urban Jail - Los Angeles County, California, May-July 2023.